These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25722224)

  • 1. Surgical menopause versus natural menopause and cardio-metabolic disturbances: A 12-year population-based cohort study.
    Farahmand M; Ramezani Tehrani F; Bahri Khomami M; Noroozzadeh M; Azizi F
    J Endocrinol Invest; 2015 Jul; 38(7):761-7. PubMed ID: 25722224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does metabolic syndrome or its components differ in naturally and surgically menopausal women?
    Farahmand M; Ramezani Tehrani F; Simbar M; Mehrabi Y; Khalili D; Azizi F
    Climacteric; 2014 Aug; 17(4):348-55. PubMed ID: 24188285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopause is an independent predictor of metabolic syndrome in Iranian women.
    Eshtiaghi R; Esteghamati A; Nakhjavani M
    Maturitas; 2010 Mar; 65(3):262-6. PubMed ID: 19962253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Cardiometabolic Effect in Bilateral/Unilateral Oophorectomy Versus Natural Menopause: Results of Over a Decade Follow-up Among Iranian Women.
    Farahmand M; Ramezani Tehrani F; Bahri Khomami M; Azizi F
    Arch Iran Med; 2017 Dec; 20(12):734-739. PubMed ID: 29664312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor analysis of metabolic syndrome components and predicting type 2 diabetes: Results of 10-year follow-up in a Middle Eastern population.
    Ayubi E; Khalili D; Delpisheh A; Hadaegh F; Azizi F
    J Diabetes; 2015 Nov; 7(6):830-8. PubMed ID: 25492310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertensive pregnancy disorders as a risk factor for future cardiovascular and metabolic disorders (Tehran Lipid and Glucose Study).
    Hashemi S; Ramezani Tehrani F; Mehrabi Y; Azizi F
    J Obstet Gynaecol Res; 2013 May; 39(5):891-7. PubMed ID: 23438323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease risk factors and menopause: a study in 1980 Tehranian women, the Tehran Lipid and Glucose Study.
    Azizi F; Ainy E
    Climacteric; 2003 Dec; 6(4):330-6. PubMed ID: 15006254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent association between age at natural menopause and hypercholesterolemia, hypertension, and diabetes mellitus: Japan nurses' health study.
    Lee JS; Hayashi K; Mishra G; Yasui T; Kubota T; Mizunuma H
    J Atheroscler Thromb; 2013; 20(2):161-9. PubMed ID: 23079582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women?
    Cagnacci A; Palma F; Romani C; Xholli A; Bellafronte M; Di Carlo C
    Gynecol Endocrinol; 2015 May; 31(5):359-62. PubMed ID: 25585548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index (BMI) as a major factor in the incidence of the metabolic syndrome and its constituents in unaffected Taiwanese from 1998 to 2002.
    Yang FY; Wahlqvist ML; Lee MS
    Asia Pac J Clin Nutr; 2008; 17(2):339-51. PubMed ID: 18586657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.
    Chen S; Guo X; Zhang X; Yu S; Yang H; Jiang M; Sun G; Sun Y
    BMC Cardiovasc Disord; 2015 Jul; 15():65. PubMed ID: 26160405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Lipid Accumulation Product with Cardio-Metabolic Risk Factors in Postmenopausal Women.
    Namazi Shabestari A; Asadi M; Jouyandeh Z; Qorbani M; Kelishadi R
    Acta Med Iran; 2016 Jun; 54(6):370-5. PubMed ID: 27306343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome.
    Cho GJ; Lee JH; Park HT; Shin JH; Hong SC; Kim T; Hur JY; Lee KW; Park YK; Kim SH
    Menopause; 2008; 15(3):524-9. PubMed ID: 18467953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome among postmenopausal women in Ecuador.
    Hidalgo LA; Chedraui PA; Morocho N; Alvarado M; Chavez D; Huc A
    Gynecol Endocrinol; 2006 Aug; 22(8):447-54. PubMed ID: 17012107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory markers and cardiovascular risks among overweight-obese Emirati women.
    Alkaabi J; Gariballa S; Sharma C; Yasin J; Essa AA; Ali H; Souid AK
    BMC Res Notes; 2016 Jul; 9():355. PubMed ID: 27440160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricemia is independently associated with left ventricular hypertrophy in post-menopausal women but not in pre-menopausal women in rural Northeast China.
    Yu S; Yang H; Guo X; Zheng L; Sun Y
    Gynecol Endocrinol; 2015; 31(9):736-41. PubMed ID: 26376959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of metabolic syndrome in urban Pakistan (Karachi): comparison of newly proposed International Diabetes Federation and modified Adult Treatment Panel III criteria.
    Hydrie MZ; Shera AS; Fawwad A; Basit A; Hussain A
    Metab Syndr Relat Disord; 2009 Apr; 7(2):119-24. PubMed ID: 18928398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS).
    Ainy E; Mirmiran P; Zahedi Asl S; Azizi F
    Maturitas; 2007 Oct; 58(2):150-5. PubMed ID: 17768019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.